Skip to main content

Closed

IMUX: Immunic, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-72.3%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio4.92×

Immunic, Inc.

IMUXNASDAQ Global Select·USD·Closed

Immunic, Inc.

IMUXNASDAQ·USD·Closed

$13.97

−0.14%

$13.97

−$0.02 (0.14%)

52W Range

83thpctl

Volume

0.37×avg

Mkt Cap

190.29MUSD

P/E

-2.3TTM

Div Yield

–ann

52W Range

83thpctl

Volume

0.37×avg

Market Cap

190.29MUSD

P/E Ratio

-2.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings